デフォルト表紙
市場調査レポート
商品コード
1738429

デジタルワクチン市場- 世界の産業規模、シェア、動向、機会、予測、デバイスタイプ別、用途別、地域別、競合別、2020-2030年

Digital Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Device Type, By Application, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 180 Pages
納期
2～3営業日
カスタマイズ可能
デジタルワクチン市場- 世界の産業規模、シェア、動向、機会、予測、デバイスタイプ別、用途別、地域別、競合別、2020-2030年
出版日: 2025年05月30日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

デジタルワクチンの世界市場規模は2024年に12億8,000万米ドル、2030年には20億3,000万米ドルに達し、CAGR 7.98％で成長すると予測されています。

デジタルワクチンは、予防ヘルスケアにおける画期的なもので、ソフトウェアベースのプラットフォームを活用し、免疫反応を調節するための神経認知・行動経路に関与させる。従来のワクチンとは異なり、これらのデジタル・ソリューションは、スマートフォン、タブレット、ウェアラブル端末を採用し、感染症、慢性疾患、メンタルヘルス状態をターゲットとした非侵襲的でカスタマイズされた介入を提供します。デジタルヘルス技術が進化し、個別化された拡張可能な予防法への需要が高まるにつれ、この市場は牽引力を増しています。世界のヘルスケアニーズの高まりと、統合されたデータ主導のケア提供へのシフトが、市場の拡大を支えています。デジタル治療薬と予防接種の交差点に位置するデジタルワクチンは、革新的で費用対効果の高い予防医療ソリューションを通じて、将来の公衆衛生戦略を再構築しています。

市場概要
予測期間 2026-2030
市場規模：2024年 12億8,000万米ドル
市場規模：2030年 20億3,000万米ドル
CAGR：2025年～2030年 7.98%
急成長セグメント スマートフォン
最大市場 北米

市場促進要因

感染症および慢性疾患の増加

主な市場課題

規制の不確実性と複雑な承認プロセス

主要市場動向

デジタルワクチンと広範なデジタル治療エコシステムとの統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 デジタルワクチン市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • デバイスタイプ別（スマートフォン、タブレット、その他）
    • 用途別（糖尿病、感染症、心血管疾患、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米のデジタルワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州のデジタルワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン

第8章 アジア太平洋地域のデジタルワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米のデジタルワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのデジタルワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 世界のデジタルワクチン市場：SWOT分析

第14章 競合情勢

  • Pfizer Inc.
  • Moderna, Inc
  • AstraZeneca Plc
  • Johnson & Johnson Service Inc.
  • Sanofi
  • GSK Plc.
  • Novavax
  • BioNTech SE
  • Bharat Biotech Ltd
  • Klein Buendel, Inc

第15章 戦略的提言

目次
Product Code: 12817

The Global Digital Vaccine Market was valued at USD 1.28 Billion in 2024 and is projected to reach USD 2.03 Billion by 2030, growing at a CAGR of 7.98%. Digital vaccines represent a breakthrough in preventive healthcare, utilizing software-based platforms to engage neurocognitive and behavioral pathways for modulating immune responses. Unlike conventional vaccines, these digital solutions employ smartphones, tablets, and wearable devices to deliver non-invasive, customized interventions targeting infectious diseases, chronic illnesses, and mental health conditions. This market is gaining traction as digital health technologies evolve and the demand for personalized, scalable prevention methods rises. Increasing global healthcare needs, coupled with the shift towards integrated, data-driven care delivery, support the market's expansion. Positioned at the intersection of digital therapeutics and immunization, digital vaccines are reshaping future public health strategies through innovative, cost-effective preventive care solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.28 Billion
Market Size 2030USD 2.03 Billion
CAGR 2025-20307.98%
Fastest Growing SegmentSmartphones
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Infectious and Chronic Diseases

The growing prevalence of infectious and chronic diseases is a primary catalyst propelling the Global Digital Vaccine Market. In 2021, non-communicable diseases accounted for over 43 million deaths, with 18 million classified as premature. These statistics are particularly concerning in low- and middle-income countries, where 82% of early deaths occurred. Concurrently, communicable diseases like tuberculosis, COVID-19, and influenza continue to impact global health, with TB alone causing 1.25 million deaths in 2023. The escalating burden on healthcare systems underscores the urgent need for preventive, scalable solutions. Digital vaccines offer timely, personalized interventions using software to manage and mitigate disease progression, thereby addressing a critical gap in traditional healthcare infrastructure.

Key Market Challenges

Regulatory Uncertainty and Complex Approval Processes

The absence of clear regulatory standards tailored for digital vaccines presents a considerable challenge for market growth. These software-based interventions straddle multiple domains-therapeutics, digital health, and preventive care-leading to ambiguity in classification and compliance. Regulatory bodies around the world differ in their evaluation and approval processes, which results in delays, inconsistent requirements, and elevated development costs. These factors deter investment, complicate commercialization, and hinder broader market adoption, especially in emerging regions.

Key Market Trends

Integration of Digital Vaccines with Broader Digital Therapeutics Ecosystems

A notable trend in the market is the merging of digital vaccines into comprehensive digital therapeutic ecosystems. Instead of operating as isolated tools, digital vaccines are increasingly becoming components of integrated health platforms that include AI diagnostics, remote monitoring, and personalized treatment. This ecosystem-based approach enhances clinical effectiveness through real-time analytics and interconnected care pathways. By fostering interoperability and cross-platform functionality, companies that prioritize ecosystem integration are poised to drive adoption and deliver greater value in preventive health.

Key Market Players

  • Pfizer Inc.
  • Moderna, Inc
  • AstraZeneca Plc
  • Johnson & Johnson Service Inc.
  • Sanofi
  • GSK Plc.
  • Novavax
  • BioNTech SE
  • Bharat Biotech Ltd
  • Klein Buendel, Inc

Report Scope:

In this report, the Global Digital Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Vaccine Market, By Device Type:

  • Smartphones
  • Tablets
  • Others

Digital Vaccine Market, By Application:

  • Diabetes
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Digital Vaccine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Vaccine Market.

Available Customizations:

Global Digital Vaccine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Digital Vaccine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device Type (Smartphones, Tablets, Others)
    • 5.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Digital Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Vaccine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Digital Vaccine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Digital Vaccine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device Type
        • 6.3.3.2.2. By Application

7. Europe Digital Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Digital Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Digital Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device Type
        • 7.3.3.2.2. By Application
    • 7.3.4. France Digital Vaccine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Digital Vaccine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Digital Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Digital Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Digital Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Digital Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Digital Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Digital Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device Type
        • 8.3.5.2.2. By Application

9. South America Digital Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Digital Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Digital Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Digital Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Digital Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Digital Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Digital Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Digital Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Digital Vaccine Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Pfizer Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Moderna, Inc
  • 14.3. AstraZeneca Plc
  • 14.4. Johnson & Johnson Service Inc.
  • 14.5. Sanofi
  • 14.6. GSK Plc.
  • 14.7. Novavax
  • 14.8. BioNTech SE
  • 14.9. Bharat Biotech Ltd
  • 14.10.Klein Buendel, Inc

15. Strategic Recommendations